Since the last time you logged in our privacy statement has been updated. We want to ensure that you are kept up to date with any changes and as such would ask that you take a moment to review the changes. You will not continue to receive KPMG subscriptions until you accept the changes.
We want to make sure you're kept up to date. Please take a moment to review these changes. You will not receive KPMG subscription messages until you agree to the new policy.
Mark joined in KPMG China in 2008 where he advises clients on investments in China including due diligence, joint ventures, vendor assistance, SPA drafting and completion accounts. Mark has extensive transaction service experiences in pharmaceutical & healthcare, consumer markets, industrial markets in China, granting his in-depth knowledge of sector characteristics and client’s primary concerns.